ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 668

Enhanced Expression Of The Cold-Sensing Receptor-TRPM8 In Scleroderma Endothelial Cells and Skin and Endothelial Dysfunction Following TRPM8 Activation

Yongqing Wang1, David R. Giovannucci2 and Bashar Kahaleh3, 1Medicine, University of Toledo, Toledo, OH, 2Neurosciences, University of Toledo, Toledo, OH, 3Medicine/Rheumatology, University of Toledo, Toledo, OH

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cell biology, endothelial cells and scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Cold exposure induces vasospasm and incites reperfusion injury in SSc. The mechanisms responsible for enhanced cold sensitivity in SSc are poorly understood. Transient receptor potential melastatine8 (TRPM8) is a well characterized cold sensing cation channel. To date, TRPM8 expression has not been described in human microvascular endothelial cells (MVEC). In this study we thought to search for TRPM8 expression in SSc MVEC and skin. We also investigated the effects of TRPM8 activation on MVEC gene expression. 

Methods: MVEC were isolated from involved SSc skin and from matched healthy control subjects. The expression of TRPM8 was determined by RT-PCR, immunohistochemistry and western blotting.  TRPM8 activation in MVEC was triggered by the TRPM8 agonist menthol or by exposure of cells to cold temperature (18C°). The intracellular calcium concentration was determined by Ca2+ microfluorometry using the prototypical TRPM8 agonist menthol.  The effects of TRPM8 activation on the mRNA expression levels of ET1, NOS3 and PTGIS and the expression levels of TRPM8 in SSc-MVEC and SSc skin biopsies were quantitated by real time PCR.

Results: TRPM8 gene and protein expression in HMVEC are demonstrated by RT-PCR, Western blotting and immunohistochemistry.  In Ca2+ microfluorometry studies, we showed increased MVEC intracellular calcium ([Ca2+]i) in response to the TRPM8 agonist menthol. The activation of the TRPM8 in HMVEC stimulated by cold significantly increased expression of ET1 (2.39 folds ± 0.21) and decreased NOS3 (62% ± 5.1 reduction) and PTGIS (61% ± 4.8) expression levels. These effects were attenuated by the addition of the TRPM8 antagonist capsazepine. Similar results were obtained with menthol treated HMVEC. The TRPM8 mRNA expression levels were significantly increased in SSc-MVEC (2.59 fold ± 0.22 vs. control MVEC) and SSc-skin biopsies (25.52 fold ± 2.28 vs. control skin biopsies).

Conclusion: The study demonstrates that human MVEC express functional TRPM8 and that there is increased expression of TRPM8 in SSc skin and in SSc-MVEC. TRPM8 may be involved in cold-induced vascular dysfunction through increase ET1, and decrease NOS3 and PTGIS mRNA expression. The increased expression levels of TRPM8 in SSc-MVECs and SSc skin may be involved in enhanced cold sensitivity in SSc.  The bulk of TRPM8 skin expression in SSc seems to be extravascular and possibly neuronal.

These results suggest that the blockade of TRPM8 activation could be an effective therapeutic strategy in SSc vasculopathy.


Disclosure:

Y. Wang,
None;

D. R. Giovannucci,
None;

B. Kahaleh,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhanced-expression-of-the-cold-sensing-receptor-trpm8-in-scleroderma-endothelial-cells-and-skin-and-endothelial-dysfunction-following-trpm8-activation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology